Airway Inflammation and Symptoms in Children Following Liver and Heart Transplantation.
1Otolaryngology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
2Pediatric Liver Care Center, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
3Division of Pediatric Pulmonology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
4Heart Institute, Cincinnati Childrens Hospital Medical Center, Cincinati, OH.
Meeting: 2016 American Transplant Congress
Abstract number: D197
Session Information
Session Name: Poster Session D: Pediatric Liver Transplantation
Session Type: Poster Session
Date: Tuesday, June 14, 2016
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
Objectives: To describe the upper airway endoscopic findings of patients with stridor, stertor or sleep-disordered breathing after liver transplantation (LT) or heart transplantation (HT).
Methods: Retrospective review of children undergoing airway evaluation after LT or HT from 2011 to 2015 at a tertiary care pediatric hospital. Airway findings, biopsy results, immunosuppressive agents and systemic Ebstein Barr virus (EBV) PCR levels were recorded.
Results: Twenty-three of 158 LT (111) or HT (47) recipients underwent airway evaluation due to airway symptoms or respiratory failure. Nine of 23 patients presented with stridor, stertor or sleep-disordered breathing. All patients were on tacrolimus and 7 had detectable EBV levels at the time of airway evaluation. Median time from LT to airway evaluation was 9 months (range 4-25) and 31 months (range 1-108) for HT. Thirteen (57%) patients had abnormal findings (7 LT; 5 HT). The most common abnormalities were epiglottic edema/thickening (75%) and arytenoid edema/thickening (100%). Of the 5 patients who underwent laryngeal biopsies, 2 were positive for EBV, of which one had histology consistent with post-transplant lymphoproliferative disorder (PTLD). The remaining 3 showed lymphocytic inflammation. One patient had laryngeal candidiasis. Immunosuppression agents were decreased in 7 of 13 patients. Three patients received corticosteroids and 3 had no change in treatment. There were no episodes of organ rejection at last follow up. No patients had airway symptoms at last follow up, which ranged from 26-1166 days after original airway evaluation.
Conclusions: Abnormal laryngeal findings are common in LT and HT recipients who undergo airway evaluation, with arytenoid and epiglottic edema/thickening most commonly seen. While these findings may be seen in PTLD, these findings in EBV-negative, PTLD-negative patients are a new observation not previously reported in the literature. These findings suggest a non-viral etiology of airway inflammation in transplant patients. Further research is needed to better define the extent and etiology of airway inflammation following pediatric liver and heart transplantation.
CITATION INFORMATION: Redmann A, Bucuvalas J, Wood R, Chin C, Hart C. Airway Inflammation and Symptoms in Children Following Liver and Heart Transplantation. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:
Redmann A, Bucuvalas J, Wood R, Chin C, Hart C. Airway Inflammation and Symptoms in Children Following Liver and Heart Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/airway-inflammation-and-symptoms-in-children-following-liver-and-heart-transplantation/. Accessed November 21, 2024.« Back to 2016 American Transplant Congress